{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:13:16Z","timestamp":1793236396247,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>End-stage renal disease (ESRD) is a major risk factor for cardiovascular disease and the prognosis after myocardial infarction (MI) is dismal. Although cardiac troponin is a key diagnostic test, troponin levels are often elevated in ESRD patients without evidence of MI. Thus, this study attempted to determine the optimal diagnostic value of high-sensitivity troponin I (hsTnI) by dialysis modality in ESRD patients.<\/jats:p>\n            <jats:p>Medical records of adult dialysis patients who visited tertiary emergency department (ED) were collected retrospectively. Diagnosis of MI was made according to the fourth universal definition of MI. The cut-off values were calculated using a receiver operating characteristic (ROC) curve.<\/jats:p>\n            <jats:p>Medical records of 1144 patients were analyzed and MI was diagnosed in 82 patients (75 on hemodialysis and 7 on peritoneal dialysis). The optimal cut-off value of hsTnI in hemodialysis patients was 75 ng\/L, with 93.33% sensitivity and 60.76% specificity. Area under the curve (AUC) was .870 (95% confidence interval (CI) .833\u2013.906). The optimal cut-off value of hsTnI in peritoneal dialysis patients was 144 ng\/L, with 100.00% sensitivity and 83.10% specificity. AUC was .943 (95% CI .893\u2013.992).<\/jats:p>\n            <jats:p>The dialysis modality should also be considered when diagnosing MI using hsTnI in ESRD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018580","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T02:31:13Z","timestamp":1580351473000},"page":"e18580","source":"Crossref","is-referenced-by-count":13,"title":["Optimal cut-off value of high-sensitivity troponin I in diagnosing myocardial infarction in patients with end-stage renal disease"],"prefix":"10.1097","volume":"99","author":[{"given":"Eunsoo","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ajou University School of Medicine, Yeongtong-gu, Suwon, Gyeonggi-do, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.117.030320","article-title":"High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome","volume":"137","author":"Miller-Hodges","year":"2018","journal-title":"Circulation"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"41350","DOI":"10.1038\/srep41350","article-title":"Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/M14-0746","article-title":"Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review","volume":"161","author":"Stacy","year":"2014","journal-title":"Ann Intern Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/ndt\/16.7.1452","article-title":"Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: chronic haemodialysis and new cardiac markers evaluation (CHANCE) study","volume":"16","author":"Iliou","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"R6-20230915","first-page":"1","article-title":"Interpretation of cardiac troponins in patients with chronic kidney disease and suspected acute coronary syndrome in the emergency setting","volume":"3","author":"Han","year":"2005","journal-title":"Emerg Med Card Res Educ Group"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"e008032","DOI":"10.1161\/JAHA.117.008032","article-title":"Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease","volume":"7","author":"Kraus","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"e82752","DOI":"10.1371\/journal.pone.0082752","article-title":"Cardiac troponin I in non-acute coronary syndrome patients with chronic kidney disease","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5858\/arpa.2014-0580-OA","article-title":"Diagnosis of acute myocardial infarction in hemodialysis patients with high-sensitivity cardiac troponin T assay","volume":"140","author":"Huang","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000480225","article-title":"Troponin I levels in asymptomatic hemodialysis patients","volume":"44","author":"Castini","year":"2017","journal-title":"Blood Purif"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.amjcard.2013.08.028","article-title":"Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency","volume":"112","author":"Pfortmueller","year":"2013","journal-title":"Am J Cardiol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.114.014245","article-title":"Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction","volume":"131","author":"Twerenbold","year":"2015","journal-title":"Circulation"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1681\/ASN.2017030341","article-title":"Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I","volume":"29","author":"Gunsolus","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1525-139X.2011.00912.x","article-title":"How should clinicians interpret cardiac troponin values in patients with ESRD?","volume":"24","author":"Jain","year":"2011","journal-title":"Semin Dial"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"e000108","DOI":"10.1136\/openhrt-2014-000108","article-title":"Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis","volume":"1","author":"Gaze","year":"2014","journal-title":"Open Heart"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.clinbiochem.2016.05.015","article-title":"Monthly reference change value of cardiac troponin in hemodialysis patients as a useful tool for long-term cardiovascular management","volume":"49","author":"Badiou","year":"2016","journal-title":"Clin Biochem"},{"issue":"(Suppl 1)","key":"R21-20230915","first-page":"35","article-title":"High sensitive troponin concentration stability in dialysate of anuric patients on hemodialysis","volume":"14","author":"Svagusa","year":"2018","journal-title":"Signa Vitae"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:49:11Z","timestamp":1694821751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018580","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}